INTRODUCTION {#h0.0}
============

*Acinetobacter baumannii* has emerged as a clinically and epidemiologically important nosocomial pathogen, essentially because of its ability to persist in the hospital environment and its propensity to rapidly acquire antibiotic resistance mechanisms ([@B1]). Multidrug-resistant *A. baumannii* strains are frequently found to be responsible for epidemics of nosocomial infections, such as respiratory, bloodstream, urinary tract, skin, and soft tissue infections ([@B1]). In addition to its high capacity to acquire new genetic determinants, overproduction of resistance-nodulation-cell division (RND) efflux pumps with broad substrate specificity has been shown to be associated with multidrug resistance (MDR) in *A. baumannii* ([@B2]). RND efflux systems, composed of an inner membrane protein (RND pump) linked by a periplasmic adaptor protein (PAP) to an outer membrane factor (OMF), can extrude a wide range of substrates often unrelated in structure ([@B3]). To date, three *Acinetobacter* drug efflux (Ade) RND systems, AdeABC ([@B4]), AdeFGH ([@B5]), and AdeIJK ([@B6]), have been characterized in *A. baumannii*. Overexpression of the AdeABC pump, primarily, and of AdeFGH plays a major role in acquired resistance ([@B2], [@B7]), whereas AdeIJK contributes to intrinsic resistance ([@B6]). Expression of each pump is tightly regulated by a different mechanism: AdeABC by a two-component regulatory system, AdeRS ([@B8]), AdeFGH by the LysR-type transcriptional regulator AdeL ([@B5]), and AdeIJK by the TetR transcriptional regulator AdeN ([@B9]). The study of the relative contributions of these three most prevalent pumps in 14 clinical isolates outlined the high incidence of *adeABC* overexpression in MDR strains, resulting from a variety of point mutations in AdeRS, whereas only half of the strains had a slight increase in *adeFGH* expression and, curiously, none overexpressed *adeIJK* ([@B7]).

Involvement of these pumps in antibiotic efflux was demonstrated by the study of *in vitro* mutants of clinical isolates overproducing the pumps and of deletion mutants obtained by insertional inactivation of the structural genes for the pumps ([@B4][@B5][@B6]) and by the use of efflux inhibitors. Interpretation of data obtained with efflux inhibitors is difficult due to their lack of specificity, their own antibacterial activity, and the multiplicity of the pumps ([@B10]). Moreover, these studies provide limited, and sometimes discrepant, findings on the respective roles of the pumps because of lack of characterization of the parental strains, which are most often MDR clinical isolates expressing complex sets of resistant determinants ([@B11]).

In an attempt to better characterize the contribution of the RND efflux systems to intrinsic or acquired resistance of *A. baumannii*, we constructed from the susceptible and entirely sequenced clinical BM4587 isolate a set of isogenic mutants (i) overproducing each of the three RND efflux systems as a result of a single mutation in their cognate regulator or (ii) deleted in each efflux system following clean allelic replacement. Pairwise comparison of every point mutant or of its deleted counterpart with the parental strain led to precise characterization of the contribution of AdeABC and AdeFGH and of the contribution of AdeIJK to acquired and intrinsic antibiotic resistance, respectively. In addition, this report documents the consequences of the level of production of the pumps for biofilm formation, host motility, competence, and conjugation, i.e., with respect to persistence of this bacterial species and horizontal acquisition of resistance genes.

RESULTS {#h1}
=======

Genomic features of *A. baumannii* BM4587. {#s1.1}
------------------------------------------

Clinical strain BM4587, isolated in 2009 in France, was previously screened for resistance determinants with a microarray and shown to be susceptible to antibiotics ([@B12]). Its genome is composed of a 3,913,120-bp circular chromosome with a 39.0% GC content similar to that of other sequenced *A. baumannii* isolates and of an 8,057-bp cryptic plasmid, pIP870. A total of 3,766 genes were annotated on the chromosome, including six rRNA clusters, 72 tRNAs, 3,665 predicted protein coding sequences (CDSs), and the three RND efflux operons, *adeABC*, *adeFGH*, and *adeIJK* (see [Table S1](#tabS1){ref-type="supplementary-material"} in the supplemental material). The AdeRS two-component regulatory system of AdeABC and the AdeL LysR-type transcriptional regulator of AdeFGH were transcribed in the opposite direction upstream from the corresponding operon, whereas the TetR-type transcriptional regulator AdeN was ca. 800 kb away from the AdeIJK operon ([Fig. 1](#fig1){ref-type="fig"}). *A. baumannii* BM4587 encodes seven RND efflux systems, but only AdeABC, AdeFGH, and AdeIJK have been functionally defined. The remaining four pumps are still putative.

![Graphical circular map of *A. baumannii* BM4587 chromosome. Circles display (from the outside) (1) genes for antibiotic resistance, motility, competence, biofilm formation, and a transposase in the clockwise direction; (2) predicted CDSs transcribed in the clockwise direction; (3) predicted CDSs transcribed in the counterclockwise direction; (4) genes for antibiotic resistance, motility, competence, and biofilm formation in the counterclockwise direction; (5) prophages; (6) Mol% G+C deviation (mean G+C content in a 1-kb window for overall mean G+C); and (7) positive (green) and negative (purple) G+C skew. CGView software ([@B60]) was utilized to construct the genome map. Genes indicated in red represent those encoding antibiotic resistance; blue, motility and competence; green, biofilm formation; gray, mobile elements; and magenta, the replication origin.](mbo0021522470001){#fig1}

In the phylogenetic tree obtained from a set of 133 core genomes of species of the genus *Acinetobacter* ([@B13]), BM4587 was positioned in the clade of the 34 *A. baumannii* spp. (average nucleotide identity, 97.7%). It was close to AB0057 ([@B14]), AYE ([@B15]), and AB307-0294 ([@B14]), which belong to international Clonal Complex 1 (CC1) ([@B13]). By MultiLocus Sequence Typing (Pasteur scheme), the allelic profile of BM4587, 1-63-2-2-9-4-3, was shown to correspond to new Strain Type 621.

*A. baumannii* is known to have a plastic genome with numerous horizontally acquired mobile genetic elements. In contrast to published chromosome sequences, including our own study results ([@B13]), no pathogenicity or resistance islands, insertion sequences (IS), transposons, or integrons were found in BM4587. We detected only a truncated gene for a transposase (76% amino acid \[aa\] identity for 50% profile coverage with transposase ISRme19) which was not associated with an IS and two 51-kb and 41-kb putative prophages related to the rare podoviral bacteriophage YMC/09/02/B1251 ABA BP ([@B16]).

Construction of isogenic mutants overproducing or deleted for Ade efflux pumps. {#s1.2}
-------------------------------------------------------------------------------

We generated *in vitro* from BM4587 spontaneous resistant mutants overproducing the three main RND efflux pumps on gradient agar plates containing gentamicin for *adeABC* and chloramphenicol for *adeFGH*, as previously described ([@B17]); the mutant overexpressing *adeIJK* was obtained previously on a cefotaxime gradient ([@B12]) (see [Table S2](#tabS2){ref-type="supplementary-material"} in the supplemental material).

The derivatives differed from the parental strain by a single point mutation in their respective regulators (see [Table S2](#tabS2){ref-type="supplementary-material"} in the supplemental material) which was confirmed by whole-genome sequencing. The two variants overexpressing *adeABC*, BM4688\[↗*adeABC*\] AdeS~R152K~ in the sensor and BM4689\[↗*adeABC*\] AdeR~A91V~ in the response regulator of the two-component regulatory system, had already-reported mutations. The AdeS~R152K~ substitution near phosphorylatable histidine 149 is a mutational hot spot in clinical isolates overexpressing *adeB* ([@B7]), and AdeR~A91V~ in the signal receiver domain was obtained *in vitro* ([@B18]). Overexpression of the pump was quantified by reverse transcription-quantitative PCR (RT-qPCR). We were able to detect *adeB* expression in the parental strain but at a very low level (0.01-fold less than that seen with *rpoB* or *secE* genes). The *adeG* expression was similarly low, less than 0.2-fold that seen with the *rpoB* and *secE*. These figures explain why there were no changes in the MIC values for both deletion mutants from those for the parental strain. In contrast, the *adeJ* gene was expressed at levels similar to (1.1-fold) those seen with *rpoB* and *secE*, which was consistent with the membrane protein data ([Table 1](#tab1){ref-type="table"}). BM4688\[↗*adeABC*\] presented expression that was increased 60-fold for *adeA*, 38-fold for *adeB*, and 10-fold for *adeC* compared to the levels seen with the parent, whereas BM4689\[↗*adeABC*\] had expression levels of *adeABC* that were nearly 5 times higher ([Fig. 2](#fig2){ref-type="fig"}).

###### 

Proteins differentially expressed in *A. baumannii* isogenic mutants BM4689\[↗*adeABC*\] and BM4666\[↗*adeIJK*\] relative to BM4587

  Location[^a^](#ngtab1.1){ref-type="table-fn"}   Protein                                                                                        BM4689\[↗*adeABC*\] vs BM4587   BM4666\[↗*adeIJK*\] vs BM4587                                            
  ----------------------------------------------- ---------------------------------------------------------------------------------------------- ------------------------------- ------------------------------- ---------- ------ ---- ------ ---------- -------
  RND efflux system                                                                                                                                                                                                                                       
      BM4587v1_20947                              AdeA                                                                                           22                              1577                            4.47e-11   65.3                          
      BM4587v1_20948                              AdeB                                                                                           4                               210                             2.89e-09   40.4                          
      BM4587v1_20949                              AdeC                                                                                           17                              991                             5.66e-11   29.5                          
      BM4587v1_10691                              AdeI                                                                                                                                                                             17   1524   1.27e-06   3.9
      BM4587v1_10690                              AdeJ                                                                                                                                                                             11   552    7.78e-04   3.8
      BM4587v1_10689                              AdeK                                                                                                                                                                             21   1786   3.56e-05   2.5
  Cell motility/adhesion                                                                                                                                                                                                                                  
      BM4587v1_21011                              FimA, fimbrial adhesin protein                                                                                                                                                   4    177    8.91e-04   −33.9
      BM4587v1_20439                              CsuA/B; putative secreted protein related to type I pili                                       5                               378                             1.69e-04   −2.5   5    754    1.19e-04   −3.2
      BM4587v1_20442                              CsuC; putative type I pilus usher pathway chaperone                                            8                               373                             3.48e-03   −2.8   7    321    2.19e-05   −6.7
      BM4587v1_10582                              Omp38, outer membrane protein A                                                                5                               190                             1.83e-05   −2.9                          
      BM4587v1_21772                              Outer membrane protein A family                                                                3                               125                             2.29e-03   2.6                           
  Metabolism/amino acid transport/biosynthesis                                                                                                                                                                                                            
      BM4587v1_20210                              DABA-AT, diaminobutyrate-2-oxoglutarate aminotransferase                                       6                               210                             2.43e-05   −3.8   7    431    4.52e-04   −2.7
      BM4587v1_21371                              Amino acid ABC transporter periplasmic protein                                                 3                               103                             1.42e-03   2.6                           
      BM4587v1_20299                              TrpC, indole-3-glycerol-phosphate synthase                                                     4                               173                             1.97e-06   −6.4   4    174    3.32e-03   −2.5
      BM4587v1_20152                              AspC, aspartate aminotransferase A                                                             4                               152                             2.40e-05   −5.7   4    246    1.36e-03   −2.5
      BM4587v1_10396                              RES, type III restriction enzyme, res subunit                                                                                                                                    3    95     1.87e-03   −5.8
      BM4587v1_22098                              BetA, oxygen-dependent choline dehydrogenase                                                   3                               162                             1.96e-03   2.6    3    130    1.23e-03   3.4
      BM4587v1_10056                              PurC, phosphoribosylaminoimidazole-succinocarboxamide synthase                                 5                               352                             2.13e-06   −3.0                          
      BM4587v1_22207                              FabD, malonyl-CoA[^e^](#ngtab1.5){ref-type="table-fn"}-\[acyl-carrier-protein\] transacylase   4                               489                             2.10e-03   −8.8   4    173    4.59e-04   −3.6
      BM4587v1_22458                              FumA, fumarate hydratase                                                                                                                                                         3    160    1.47e-03   −2.6
      BM4587v1_20069                              EtfA, electron transfer flavoprotein alpha-subunit                                             3                               682                             9.14e-05   −2.5                          
  DNA recombination                                                                                                                                                                                                                                       
      BM4587v1_10194                              Ssb, ubiquitous ssDNA[^f^](#ngtab1.6){ref-type="table-fn"} binding protein                     4                               158                             6.86e-04   −2.4                          

Structural gene location in *A. baumannii* BM4587 chromosome.

Number of peptides for identification and quantification.

Confidence score for identification by Mascot software.

Fold change between the isogenic mutant and the parental strain; only values above a 2-fold change are indicated; negative values indicate underproduction.

CoA, coenzyme A.

ssDNA, single-stranded DNA.

![Relative levels of expression of *ade* operons. Gene expression relative to that of *rpoB* was determined by RT-qPCR. Results are presented relative to parental BM4587 taken as a reference. Every isolate was tested in duplicate in two independent experiments. The bars represent the means and the error bars the standard deviations. Genes indicated in white represent those encoding periplasmic adaptor proteins; black, RND pumps; and gray, outer membrane factors. \*\*, *P* \< 0.01; \*, *P* \< 0.05 (Student *t* test).](mbo0021522470002){#fig2}

Two *adeFGH*-overexpressing derivatives, BM4690\[↗*adeFGH*\] with an AdeL~Q332stop~ mutation and BM4691\[↗*adeFGH*\] with AdeL~N334H~, were obtained. Mutations in the C-terminal region of LysR-type regulators confer constitutive expression of the target genes ([@B5]). In the two mutants, *adeFGH* was greatly (ca. 80 to 750 times) overexpressed compared with the BM4587 results ([Fig. 2](#fig2){ref-type="fig"}).

The BM4666\[↗*adeIJK*\] derivative has an *adeN*~Δ*C584*~ mutation ([@B9]) and presented expression that had increased 13-fold for *adeI*, 6-fold for *adeJ*, and 10-fold for *adeK* ([Fig. 2](#fig2){ref-type="fig"}). AdeN is a transcriptional regulator belonging to the TetR family ([@B9]), and, as already mentioned, the coding gene is located 802 kb distant from the *adeIJK* operon ([Fig. 1](#fig1){ref-type="fig"}). To characterize potential global regulatory activity frequently associated with this type of transcriptional activator, Biolog phenotypic microarray analysis was carried out for BM4666\[↗*adeIJK*\] in comparison with BM4587. This array measures bacterial respiration changes under different culture conditions. The responses to the various antibiotics were consistent with the decreased susceptibility of the mutant to the drugs (see below and [Table 2](#tab2){ref-type="table"}). Otherwise, no significant changes were found under conditions of different carbon, nitrogen, phosphorus, sulfur, and peptide nitrogen sources and various osmolarity and pH levels (data not shown). Strain BM4666\[↗*adeIJK*\] showed only a slight stimulation of respiration in the presence of adenine, adenosine, or Tween 20. Of note, mutated AdeN resulted in moderate overexpression of the pump, as already reported for other *in vitro* mutants ([@B9]). Analysis of *adeN* loci in 34 *A. baumannii* genomes ([@B13]) showed that high deduced aa conservation, with only three strains in which AdeN was truncated, was associated with 4-fold, 3-fold, and 3-fold increased *adeJ* expression relative to BM4587 taken as a reference.

###### 

Antimicrobial susceptibility of *A. baumannii* BM4587 and derivatives

  Antimicrobial agent                                 MIC[^a^](#ngtab2.1){ref-type="table-fn"} (µg/ml)                                                   
  --------------------------------------------------- -------------------------------------------------- ---------- ------- ---------- ------- --------- -----------
  β-Lactams                                                                                                                                              
      Ampicillin                                      8                                                  **32**     8       16         8       8         8
      Ticarcillin                                     8                                                  8          8       4          8       **32**    **2**
      Aztreonam                                       32                                                 16         32      16         32      **128**   **4**
      Cephalothin                                     128                                                128        128     64         128     **512**   128
      Cefuroxime                                      16                                                 16         16      32         16      **64**    **2**
      Ceftriaxone                                     4                                                  4          4       2          2       **16**    4
      Ceftazidime                                     4                                                  **16**     4       4          4       8         **1**
      Cefepime                                        1                                                  **16**     1       0.5        1       **4**     0.5
      Imipenem                                        0.125                                              **0.5**    0.125   0.125      0.125   0.125     0.125
      Meropenem                                       0.5                                                **2**      0.5     0.5        0.5     **2**     **0.125**
      Doripenem                                       0.25                                               **4**      0.25    0.25       0.25    0.5       0.125
  Aminoglycosides                                                                                                                                        
      Streptomycin                                    32                                                 **1024**   32      32         32      32        32
      Neomycin B                                      2                                                  **16**     2       2          2       2         2
      Kanamycin                                       4                                                  **32**     4       4          4       4         4
      Tobramycin                                      2                                                  **16**     2       2          2       2         2
      Amikacin                                        2                                                  **16**     2       2          2       2         2
      Gentamicin                                      1                                                  **32**     1       1          1       1         1
      Netilmicin                                      1                                                  **128**    1       1          1       1         1
  Quinolones                                                                                                                                             
      Nalidixic acid                                  4                                                  8          4       **32**     2       8         **1**
      Norfloxacin                                     2                                                  **32**     2       **16**     2       **16**    **0.25**
      Ciprofloxacin                                   0.125                                              **1**      0.125   **1**      0.125   **0.5**   **0.016**
  Polymyxin                                                                                                                                              
      Colistin[^b^](#ngtab2.2){ref-type="table-fn"}   0.5                                                0.5        0.5     0.5        0.5     0.5       0.5
  Tetracyclines                                                                                                                                          
      Tetracycline                                    0.5                                                **4**      0.5     0.5        0.5     **2**     **0.063**
      Minocycline                                     0.25                                               0.25       0.25    0.25       0.125   0.5       **0.015**
      Tigecycline                                     0.125                                              **2**      0.125   0.25       0.125   **0.5**   **0.031**
  Macrolide-lincosamide                                                                                                                                  
      Erythromycin                                    64                                                 **256**    64      128        64      128       **8**
      Clindamycin                                     512                                                **2048**   512     1024       512     1024      **16**
  Phenicol                                                                                                                                               
      Chloramphenicol                                 64                                                 **256**    64      **512**    64      **256**   **16**
  Antifolates                                                                                                                                            
      Trimethoprim                                    16                                                 32         16      **64**     16      **128**   **2**
      Sulfadoxine                                     128                                                128        128     **1024**   128     256       **8**
  Miscellaneous                                                                                                                                          
      Fusidic acid                                    128                                                128        256     128        256     **512**   **8**
      Rifampin                                        1                                                  1          1       1          1       2         0.5
      Triclosan                                       4                                                  4          4       8          4       8         1

MICs were determined by microdilution according to the CLSI guidelines ([@B54]). Data in bold indicate values ≥4 times the parental strain value.

Microdilution MICs of colistin were determined according to the CLSI guidelines with the addition of Tween 80 at a final concentration of 0.002%.

Clean-deletion mutants BM4717\[Δ*adeB*\], BM4718\[Δ*adeG*\], and BM4719\[Δ*adeJ*\], lacking an RND pump gene, were obtained by two-step allelic exchange (see [Fig. S1](#figS1){ref-type="supplementary-material"} in the supplemental material) ([@B19]), and expression of the genes for the PAP, RND, and outer membrane protein (OMP) components was determined by RT-qPCR ([Fig. 2](#fig2){ref-type="fig"}). As expected, there was no expression of the deleted genes and the genes for the PAPs were expressed at levels similar to those in the parental strain. In contrast, the genes for OMPs were expressed at levels less than half of those of the parental strain in both the BM4717\[Δ*adeB*\] and BM4719\[Δ*adeJ*\] derivatives.

In contrast to report by others ([@B10]), we did not observe any alterations in the expression of the other Ade RND systems in the overproducing or deleted mutants for a single pump (data not shown).

*A. baumannii* BM4587 and isogenic mutants overproducing or deleted for Ade efflux pumps allow identification of antibiotic substrates. {#s1.3}
---------------------------------------------------------------------------------------------------------------------------------------

Broad intrinsic resistance in *A. baumannii* is due to low membrane permeability, the presence of chromosomally encoded β-lactamases, and basal expression of efflux systems. MDR in this species results from horizontal gene transfer but also from overexpression of the pumps ([@B1], [@B2]).

Genes responsible for intrinsic and acquired resistance to antibiotics were searched for in the BM4587 genome ([Fig. 1](#fig1){ref-type="fig"}; see also [Table S3](#tabS3){ref-type="supplementary-material"} in the supplemental material). The genes for the two intrinsic β-lactamases of *A. baumannii*, *bla*~ADC~ for an AmpC-type cephalosporinase (99% identical to ADC-52) and *bla*~OXA-104~ for an OXA-51-type β-lactamase, were present. The *craA* gene for a chloramphenicol-specific major facilitator superfamily (MFS) efflux system was also found ([@B20]). An acquired *aadA1* gene for a streptomycin 3′-*O*-adenylyltransferase accounted for high-level streptomycin resistance of BM4587. In contrast, acquired gene *tetA* for an MFS pump did not confer resistance, as was the case for 6 of 14 *A. baumannii* isolates in our previous study ([@B13]).

Based on the drug MIC changes with respect to the pump mutants ([Table 2](#tab2){ref-type="table"}), ampicillin for AdeABC and ticarcillin and aztreonam for AdeIJK were weakly extruded. All cephalosporins were substrates for AdeIJK, and ceftazidime and cefepime were also substrates for AdeABC. The three carbapenems were substrates for AdeABC, but only meropenem was a substrate for AdeIJK. Of note, against the Δ*adeJ* variant, but not against the Δ*adeB* and Δ*adeG* variants, the MICs of most β-lactams were lower than those against parental BM4587, indicating basal expression of AdeIJK, responsible for intrinsic resistance to these drugs, in the latter strain. These data confirm our earlier reports based on overexpressing and single-deletion or double-deletion derivatives ([@B4], [@B6], [@B9]) and are in good agreement with those obtained by others ([@B11], [@B21][@B22][@B23]) except for meropenem-AdeIJK in a single study ([@B11]). That discrepancy could have resulted from the study of an MDR strain producing a carbapenemase ([@B11]) masking the moderate effect of efflux on carbapenems. No overexpression of *ampC* or OXA-51 was detected in strain BM4666\[↗*adeIJK*\]. RT-qPCR experiments were carried out to determine if the expression of intrinsic *ampC* and *bla*~OXA-51-like~ genes was altered by the upregulation of the various efflux systems. No overexpression of *ampC* or of *bla*~OXA-51-like~ was detected in the BM4666\[↗*adeIJK*\] and BM4690\[↗*adeFGH*\] strains. There was a significant 2-fold-lower level of production of both β-lactamases in strain BM4689\[↗*adeABC*\]. Therefore, the increase in the MICs of carbapenems against the *adeABC*-overexpressing mutant was not the result of overexpression of the structural genes for the enzymes but was due solely to efflux of the drugs.

All aminoglycosides were substrates for AdeABC. Importantly, overexpression of the pump resulted in strain BM4689\[↗*adeABC*\] being categorized as clinically resistant to gentamicin, netilmicin, and tobramycin ([@B24], [@B25]).

Strain BM4587 was susceptible to nalidixic acid, norfloxacin, and ciprofloxacin; these quinolones were substrates for the three RND pumps.

Tetracycline and tigecycline were substrates for the AdeABC and AdeIJK pumps and minocycline for AdeIJK only. This was not found in another study for minocycline-AdeABC and tetracycline-AdeIJK ([@B22]) and could have been due to the fact that the experiments were carried out in different bacterial hosts, *A. baumannii* and *Escherichia coli*, which differ drastically in their outer membrane permeability ([@B26]).

Although macrolides and lincosamides are thought to be inactive against Gram-negative bacteria because of impermeability associated with the outer membrane ([@B27]), erythromycin and clindamycin were good substrates for AdeABC and AdeIJK. The MICs of both drugs against strain BM4719\[Δ*adeJ*\] were largely decreased, indicating that efflux contributes significantly to intrinsic resistance to these two classes of drugs in *A. baumannii*.

Chloramphenicol was a substrate for the three RND pumps. The MIC of the drug against parental BM4587 dropped from 64 µg/ml to 16 µg/ml for strain BM4719\[Δ*adeJ*\], indicating that efflux contributes more to intrinsic resistance to chloramphenicol than the MFS pump CraA.

*Acinetobacter* spp. are intrinsically resistant to low levels of trimethoprim and sulfonamides ([@B27]) due to AdeIJK activity; they were also substrates for AdeFGH. The AdeIJK system was also responsible for intrinsic resistance to fusidic acid and, to a much lesser extent, to rifampin.

Colistin, which acts at the surface of the cells, was not a substrate for any of the pumps.

The susceptibility of strains BM4717\[Δ*adeB*\] and BM4718\[Δ*adeG*\] was similar to that of parent strain BM4587, indicating that both the AdeABC system and the AdeFGH system are tightly regulated and are expressed only following induction by as-yet-unknown signals or mutations in the cognate regulatory system ([@B5], [@B8]). There was good correlation between the level of AdeABC expression and that of resistance to the substrate drugs, since the MICs of substrate antibiotics against strain BM4689\[↗*adeABC*\] were 1- to 4-fold higher than against strain BM4688\[↗*adeABC*\], which overexpressed *adeB* at a level 4 times lower (data not shown).

Of note, deletion mutant BM4719\[Δ*adeJ*\] had increased susceptibility to several antibiotic classes, β-lactams, quinolones, tetracyclines, MLS, phenicols, antifolates, fusidic acid, and the biocide triclosan ([Table 2](#tab2){ref-type="table"}), consistent with constitutive production of AdeIJK and with a major contribution of that pump to the broad intrinsic resistance of *A. baumannii*.

*E. coli*-*A. baumannii* shuttle plasmid pCM88 confers resistance to carbapenems by production of β-lactamase OXA-23 and to gentamicin by production of an AAC(3)-I (unpublished data). This plasmid was electrotransformed into BM4587 and its derivatives overexpressing the three efflux systems, and the MICs of antibiotics for the transformants were determined (see [Table S4](#tabS4){ref-type="supplementary-material"} in the supplemental material). There was no consequence of overexpression of the AdeFGH and AdeIJK pumps with respect to the levels of resistance of the host strains (data not shown). In contrast, the MICs of the carbapenems were 2-fold to 4-fold more elevated against strain BM4689\[↗*adeABC*\]/pCM88, and the gentamicin MICs against that strain increased from 2,048 µg/ml to more than 4,096 µg/ml. Since AdeABC is the only system that can extrude the carbapenems and the aminoglycosides, these data indicate an effect that is synergistic between efflux and other resistance mechanisms.

Overexpression of *adeABC* and *adeIJK* alters bacterial membrane composition. {#s1.4}
------------------------------------------------------------------------------

The proteomic analysis was performed on cell envelope proteins and membrane or membrane-associated proteins from both inner and outer membranes, obtained from 4-h bacterial cultures as previously described ([@B28]). Comparative study of the envelope proteins of *A. baumannii* BM4587 and of the mutants ([Table 1](#tab1){ref-type="table"}) confirmed overproduction of the AdeA, AdeB, and AdeC proteins (65-, 40-, and 29-fold changes, respectively) in strain BM4689\[↗*adeABC*\] and of AdeI, AdeJ, and AdeK (3.9, 3.8, and 2.5, respectively) in strain BM4666\[↗*adeIJK*\]. These data were in good agreement with those given by RT-qPCR analysis ([Fig. 2](#fig2){ref-type="fig"}). In the parental strain, only AdeA and AdeC proteins from the AdeABC system were detected, whereas all three proteins from the AdeIJK system were easily detected (data not shown). These observations reinforce the notions that AdeABC is expressed at a low level in the susceptible parent strain, its expression being under stringent control ([@B8]), and that AdeIJK is constitutively expressed ([@B6]). Besides the overproduction of these Ade proteins, we noticed underproduction of several interesting proteins in the mutants ([Table 1](#tab1){ref-type="table"}): (i) the CsuA/B and CsuC proteins underproduced in both mutants are part of the CsuA/BABCDE type I pilus system required for attachment to abiotic surfaces and for biofilm formation ([@B28], [@B29]); (ii) in strain BM4666\[↗*adeIJK*\], a fimbrial protein also involved in biofilm formation ([@B30]) was extremely underproduced (34-fold); and (iii) in strain BM4689\[↗*adeABC*\], production of the major OmpA protein, which plays a partial role in biofilm formation on plastic and is essential for bacterial adherence to A549 epithelial cells ([@B31]), was decreased nearly 3-fold. Finally, both mutants underproduced the diaminobutyrate-2-oxoglutarate aminotransferase (DABA-AT) involved in biosynthesis of diaminopropane (DAP), a polyamine required for *A. baumannii* surface-associated motility ([@B32]). Taken together, these data suggest possible impairment in adhesion, biofilm formation, and motility of the mutants overexpressing *adeABC* and *adeIJK*.

Overexpression of Ade efflux pumps diminishes biofilm formation but not motility. {#s1.5}
---------------------------------------------------------------------------------

*A. baumannii* displays several forms of motility on wet surfaces, including twitching motility at the agar-petri dish interface, which is, in part, driven by type 4 pili (T4P) ([@B33]), and the form of surface motility called "swarming"; both types have been shown to depend on the synthesis of 1,3-diaminopropane ([@B32]). There was no difference between parental BM4587 and the mutants in the extent of motility. All the strains moved with spreading zones of similar sizes at the agarose surface and at the interface between agarose and the polystyrene of the petri dish (see [Fig. S2](#figS2){ref-type="supplementary-material"} in the supplemental material). Formation of biofilms by *A. baumannii* BM4587 and the mutants on a solid support and at the air-liquid interface was quantified by a crystal violet colorimetric assay ([Fig. 3](#fig3){ref-type="fig"}). Consistent with the results of proteomic analyses, overexpression of the efflux pumps resulted in a decrease of biofilm and pellicle formation at 48 h. The phenomenon was clearly highlighted by experiments performed in 24-well plates ([Fig. 3](#fig3){ref-type="fig"}, white bars) that concomitantly took into account the formation of pellicles and biofilms on the walls of the well. If the impact on the BM4666\[↗*adeIJK*\] mutant remained moderate, with a 36% decrease in biofilm formation, the impact on the other mutants was much more important, with 59%, 63%, and 82% decreases for mutants BM4688\[↗*adeABC*\], BM4689\[↗*adeABC*\], and BM4690\[↗*adeFGH*\], respectively. Deletion of the genes for the RND efflux pump in the BM4718\[Δ*adeG*\] and BM4719\[Δ*adeJ*\] mutants restored the biofilm and pellicle phenotypes of parent BM4587 ([Fig. 3](#fig3){ref-type="fig"}). The Δ*adeB* mutant still had a significant defect of 39% in biofilm formation, thus presenting behavior similar to that of *E. coli* and *Salmonella enterica*, in which the deletion or inhibition of their efflux pumps was associated with decreased biofilm formation ([@B34], [@B35]).

![Biofilm and pellicle formation by *A. baumannii* BM4587 and its derivatives. Black bars, biofilms formed on Calgary device pegs; white bars, biofilms and pellicles formed on 24-well plates. Percentages indicate 48-h biofilm formation relative to parental BM4587 results taken as a reference. Experiments were performed least three times independently, and results are presented as means ± SE. \*\*\*, *P* \< 0.0001; \*\*, *P* \< 0.001; \*, *P* \< 0.05. Numbers in parentheses indicate fold increase in overexpression of the pump.](mbo0021522470003){#fig3}

Influence of overexpression of Ade efflux pumps on natural transformation. {#s1.6}
--------------------------------------------------------------------------

The emergence of MDR *A. baumannii* relies, in part, on acquisition of resistance determinants by horizontal gene transfer. This can occur via conjugation, transduction, or transformation. Since DNA uptake by transformation involves membrane structures such as T4P and takes place during adhesion and twitching mobility ([@B33], [@B36]), increased expression of efflux systems could alter cell competence. Motility and DNA uptake are associated with T4P and are abolished by inactivation of *pilT*, which encodes the T4P retraction ATPase, and of ComEC, a DNA uptake channel. The genes for all key T4P components and competence factors are present in the chromosome of strain BM4587 ([Fig. 1](#fig1){ref-type="fig"}; see also [Table S3](#tabS3){ref-type="supplementary-material"} in the supplemental material).The transformation frequencies of the parental strain and of the mutant derivatives during twitching motility were determined using genomic DNA of *A. baumannii* mutant 179, which has a kanamycin resistance gene cassette inserted in the sulfite reductase gene ([@B36]). Strain BM4587 was naturally transformable at a very low rate, 3.0 × 10^−10^ (± 1.4 × 10^−10^), and the transformation frequencies of the pump mutants were similarly low. Under these conditions, competence was detected in only 10 of 28 clinical isolates with various transformation rates (from 1 × 10^−4^ to 6 × 10^−8^) and only while twitching on semisolid medium was occurring ([@B36]). Similarly, only three of nine fully sequenced *A. baumannii* strains possessing all the competence genes ([@B13]) had transformation efficiencies higher than 10^−8^. To study the influence of *adeABC* overexpression on transformation, we performed selection on gentamicin from the most transformable strain, *A. baumannii* clinical NIPH 67 ([@B13]), an *adeABC*-overexpressing mutant. This derivative had the same mutation, AdeS~R152K~, as the BM4688\[↗*adeABC*\] mutant and displayed expression of *adeB* that was 31-fold increased relative to that of NIPH 67. Its transformation frequency (6 × 10^−9^ ± 3 × 10^−9^, *P* \< 0.05) was 4.1-fold lower than that of parental strain NIPH 67 (2 × 10^−8^ ± 9 × 10^−9^), suggesting that overexpression of *adeABC* reduces DNA uptake by the host.

Plasmid transfer is diminished by overexpression of *adeABC* and *adeIJK* in the recipient. {#s1.7}
-------------------------------------------------------------------------------------------

In the genome of *A. baumannii* BM4587, there were no type IV secretion systems which are involved in conjugation and the pIP870 resident plasmid is cryptic and not self-transferable. Conjugation was carried out using as a donor *A. baumannii* NIPH 527 harboring the 6-kb mobilizable pRAY plasmid conferring resistance to kanamycin ([@B37]) which is widely distributed in *A. baumannii* ([@B38]). Since strain NIPH 527 has the MPF~I~ conjugation machinery integrated in its chromosome ([@B13]), it can mobilize the Tra^−^ Mob^+^ pRAY plasmid. In liquid medium, the frequency of transfer to strain BM4587 was 1.4 × 10^−4^ and was significantly (*P* \< 0.05) reduced to strain BM4689\[↗*adeABC*\] (2.5 × 10^−5^) and strain BM4666\[↗*adeIJK*\] (1.2 × 10^−5^) ([Fig. 4](#fig4){ref-type="fig"}, top panel). The frequency of transfer to strain BM4717\[Δ*adeB*\] was significantly increased (5.7 × 10^−4^, *P* \< 0.01), but the frequency of transfer to strain BM4719\[Δ*adeJ*\] (2.0 × 10^−4^) remained unchanged. *A. baumannii* BM4587 and its derivatives overexpressing or deleted for *adeABC* were also used as recipients in filter-mating experiments performed with *A. baumannii* BM2580 harboring pIP1841, a plasmid self-transferable to various *Acinetobacter* spp., such as *A. baumannii*, *A. haemolyticus*, and *A. lwoffii* ([@B39]). The frequency of transfer of pIP1841 to BM4587 was 1.5 × 10^−7^ (± 1.2 × 10^−7^) ([Fig. 4](#fig3){ref-type="fig"}, bottom panel). The efficiency of conjugation to strain BM4689\[↗*adeABC*\] was half that seen with the parent strain, whereas that to strain BM4717\[Δ*adeB*\] was 2.2-fold higher. Taken together, these data indicate a decrease in conjugation efficiency for both plasmid transfer types in the *adeABC*-overexpressing derivative.

![Effect of overproduction or deletion of Ade efflux pumps on plasmid transfer. Conjugation experiments were carried out in liquid (top) or on solid (bottom) medium. Relative plasmid transfer frequency data represent the ratio of transconjugants per donor to that of parental BM4587 used as a recipient. The data are the means and standard deviations of the results of at least seven independent experiments. \*\*, *P* \< 0.001; \*, *P* \< 0.05.](mbo0021522470004){#fig4}

DISCUSSION {#h2}
==========

The antibiotic substrate range of the three RND efflux systems was determined by comparing the phenotype of strain BM4587 with those of single-mutation derivatives overexpressing or deleted for each pump ([Table 2](#tab2){ref-type="table"}). The AdeABC mutants were representatives of the clinical isolates, since they harbored the mutations in AdeR and AdeS that are the most commonly found in clinical settings and which conferred similar levels of overexpression of the pump ([@B7]). To the best of our knowledge, no clinical strains with high-level production of *adeFGH* have been reported, whereas *adeIJK* is rarely overexpressed (7, 21; unpublished data on a collection of 25 entirely sequenced *A. baumannii* strains described in reference 13). The data indicate that AdeABC, which was found in 80% of *A. baumannii* isolates, could extrude a wide range of antibiotics, including the majority of β-lactams and aminoglycosides, the fluoroquinolones, tetracyclines-tigecycline, the macrolides-lincosamides, and chloramphenicol. The mutant deleted for *adeB* had MICs of all antibiotics indistinguishable from those against parental BM4587, confirming that this pump is tightly regulated by the AdeRS two-component system ([@B8]) and does not contribute to intrinsic resistance of *A. baumannii*. Antibiotic efflux occurs only when the pump is overexpressed and, for certain drug classes, such as aminoglycosides, can result in clinical resistance. In addition to the excellent correlation between the data obtained following overexpression of the pumps and that obtained following deletion, which reinforces our conclusions on the substrate specificities of this system, there was also a good relationship between the level of expression of AdeABC and that of resistance which could lead to differences in clinical categories for doripenem and tobramycin of mutants overexpressing *adeABC* at various levels ([Fig. 2](#fig2){ref-type="fig"} and data not shown). This implies that one should exert caution in assigning substrates to a pump using a single overproducing variant.

Importantly, we observed that overexpression of *adeABC*, which extrudes carbapenems and aminoglycosides, combined with enzymatic resistance to these two classes of drugs, contributes in a more than additive fashion to the level of resistance of the host (see [Table S4](#tabS4){ref-type="supplementary-material"} in the supplemental material).

The AdeIJK system, which is present in all strains ([@B6], [@B13]), had an extremely broad substrate specificity. The MICs of the antibiotics that were substrates for AdeIJK were always lower against the *adeJ*-deleted derivative than against parental BM4587. This indicates that synthesis of AdeIJK is constitutive, as also demonstrated by analysis of membrane proteins ([Table 1](#tab1){ref-type="table"}), and that the pump is responsible for intrinsic resistance of *A. baumannii* to all major classes of antibiotics, including β-lactams, fluoroquinolones, tetracyclines, MLS, phenicols, antifolates, and fusidic acid.

While proteomic analysis of bacterial membranes confirmed the constitutive expression of AdeIJK, we highlighted, in mutants overexpressing *adeABC* and *adeIJK*, the concomitant underexpression of proteins belonging to chaperone-usher (CU) pilus assembly systems ([Table 1](#tab1){ref-type="table"}): (i) the CsuA/B and CsuC proteins, which are part of the CsuA/BABCDE type I pilus system, the expression of which is activated by the BfmRS transcriptional regulatory system ([@B29], [@B40]), and (ii) the FimA fimbrial protein. Pilus systems are known to have a major role in establishing the initial stages of biofilm formation, promoting initial adhesion and surface colonization but also formation of microcolonies ([@B41]). Both pilins CsuA/B and FimA were detected in the matrix of different *A. baumannii* pellicles ([@B42]), and the disruption of both CU systems results in a severe decrease in biofilm formation on abiotic surfaces ([@B29], [@B30]). Furthermore, the OmpA major outer membrane protein, also underexpressed in the BM4689\[↗*adeABC*\] mutant, is an adhesin required for bacterial adherence to epithelial cells and contributes to the process of biofilm formation ([@B31]). Therefore, reduced production of these proteins correlated well with the decrease in formation of biofilm and pellicle by the mutants overexpressing the efflux pumps ([Fig. 3](#fig3){ref-type="fig"}). It may be noted that such a negative correlation between overexpression of efflux systems leading to antibiotic resistance and decreases in biofilm formation has recently been observed in a transcriptomic analysis of imipenem-selected *A. baumannii* ([@B43]). Conversely, a high capacity of MDR clinical isolates of *A. baumannii* to form biofilm and to adhere to respiratory epithelial cells has been previously demonstrated ([@B44]). The contribution of Ade efflux systems to the decrease in biofilm formation remains difficult to explain. But it has been shown in *P. aeruginosa* that biofilm formation and antibiotic resistance could be controlled antagonistically via the Roc two-component systems. The *cupC* genes for Cup fimbriae (assembled by the *c*haperone-*u*sher *p*athway) contributing to biofilm formation would be upregulated by these regulators, whereas the *mexAB* and *OprM* genes would be concomitantly downregulated ([@B41]). The proteomic analysis also demonstrated a reduction of the expression of DABA-AT, involved in biosynthesis of DAP in the mutants overexpressing *adeABC* and *adeIJK* ([Table 1](#tab1){ref-type="table"}). In *Yersinia pestis*, the absence of polyamines reduces drastically the expression of the HmsR and HmsS hemin storage proteins that are involved in poly-N-acetylglucosamine polysaccharide synthesis and the expression of HmsT, a diguanylate cyclase responsible for the synthesis of the secondary messenger c-di-GMP (cyclic diguanosine-5′-monophosphate), a key regulator in biofilm formation ([@B45], [@B46]). Thus, in mutants of *Y. pestis* and *Vibrio cholerae* deficient in synthesis of putrescine and norspermidine polyamines, respectively, biofilm formation is severely impaired ([@B47], [@B48]). It appears that, similarly, reduced synthesis of DAP in *A. baumannii* may contribute to the decrease in biofilm formation.

Deletion or inhibition of efflux pumps in *E. coli* and *S. enterica* has been associated with a significant decrease of biofilm formation ([@B34], [@B35], [@B49]). However, in *A. baumannii*, biofilm formation by the mutants lacking RND pump genes *adeG* and *adeJ* was very similar to that of the parental strain. Only the Δ*adeB* mutant presented a significant defect in biofilm formation ([Fig. 3](#fig3){ref-type="fig"}). In *S. enterica*, this defect was demonstrated to be related to repression of curli biosynthesis ([@B50]), but *A. baumannii* BM4587 lacks the homologous *cgs* genes involved in the curli biosynthesis pathway. Of note, exposure of *P. aeruginosa* to efflux inhibitors does not result in a significant reduction of biofilm formation ([@B34]). The impact of expression or inhibition of efflux systems on biofilm formation may be dependent on the bacterial species.

In addition to efflux, emergence of MDR *A. baumannii* relies on the ability to acquire antibiotic resistance genes by horizontal transfer*. A. baumannii* possesses the complete set of genes required for transformation ([@B13]), but natural competence in association with T4P production and twitching motility in a clinical isolate was found only recently ([@B33]). DNA uptake was further demonstrated in 10 of 28 clinical isolates with various transformation rates (from 1 × 10^−4^ to 6 × 10^−8^) but only while the organisms were moving on semisolid media ([@B36]). Strain BM4587 was not transformable under similar conditions, although twitching mobility was observed. Of note, there were no differences in two types of motility, twitching and surface mobility, between parental BM4587 and the mutants, although proteomic analysis of the BM4689\[↗*adeABC*\] and BM4666\[↗*adeIJK*\] mutants demonstrated underexpression of the DABA-AT involved in biosynthesis of DAP a polyamine required for *A. baumannii* surface-associated motility ([@B32]). The impact of the level of AdeABC pump production on competence was thus studied with another pair of isogenic strains, and the results demonstrated a diminution of transformation in the overexpressing mutant. Of note, a 2.4-fold decrease of an Ssb single-stranded DNA binding protein was observed in the membrane of the BM4689\[↗*adeABC*\] mutant ([Table 1](#tab1){ref-type="table"}). In Gram-positive bacteria, protein SsbB is increasingly expressed during competence for genetic transformation ([@B51]).

These observations indicate that the inducing conditions for competence in *A. baumannii* are still poorly understood. Exposure of some bacterial species to certain antibiotics, in particular, bactericidal drugs, induces competence ([@B52]). Overexpression of efflux pumps, as a result of increases in the MICs of a large number of antibiotics, allow cells to survive in the presence of the drugs, providing them with a longer period of time to become competent and, ultimately, MDR by acquisition of foreign resistance genes. The influence of antibiotics on *A. baumannii* natural transformation remains to be studied. The biological cost of overproduction of the various efflux systems and the putative consequences with respect to the virulence of the host are currently under study.

In two types of plasmid transfer, mobilization and conjugation, overexpression of *adeABC* and *adeIJK* by the recipient resulted in reproducible reduction of transfer frequencies ([Fig. 4](#fig3){ref-type="fig"}). It thus appears that, if overexpression of pumps contributes to MDR by efflux, it decreases acquisition of foreign DNA by both transformation and conjugation. Alternatively, if acquisition of exogenous resistance genes occurs first, then efflux contributes in a synergistic manner, quantitatively and qualitatively, to resistance of the host.

In conclusion, our report stresses that, to be truly informative on the substrate ranges and the contribution of efflux systems to acquired and intrinsic resistance to antibiotics, the work (i) should be carried out on the bacterium of interest, rather than on a surrogate species, because of the impact of variations in levels of outer membrane permeability on the resistance phenotype, (ii) should be carried out on isogenic single-mutant derivatives overexpressing and deleted for each pump derived from a susceptible strain and (iii) should be carried out on those harboring various mutations reflecting the genetic events most commonly found in clinical isolates because of the important contribution of the levels of expression of the structural genes for the various systems, and (iv) should address the putative synergism between the pumps and the other mechanisms of resistance to a given substrate.

MATERIALS AND METHODS {#h3}
=====================

Bacterial strains, plasmids, and growth conditions. {#s3.1}
---------------------------------------------------

The bacterial strains and plasmids used in this study are described in [Table S2](#tabS2){ref-type="supplementary-material"} in the supplemental material. Bacteria were grown using brain heart infusion (BHI) or Luria-Bertani (LB) broth or agar at 37°C. Antibiotic susceptibility was determined by disk diffusion on Mueller-Hinton (MH) agar ([@B53]), and the MICs were determined by microdilution in cation-adjusted MH broth according to the CLSI guideline ([@B54]).

Selection of mutants overproducing RND efflux pumps. {#s3.2}
----------------------------------------------------

Spontaneous mutants were obtained from susceptible clinical isolate *A. baumannii* BM4587 ([@B12]) on BHI gradient plates ([@B17]) containing 0 to 64 µg/ml of gentamicin for *adeABC* and 0 to 1,000 µg/ml chloramphenicol for *adeFGH*. Colonies growing at concentrations higher than the MIC were tested for antibiotic resistance by disk diffusion, and those resistant to several drug classes were selected for RT-qPCR analysis to quantify the expression level of each RND pump.

Whole-genome sequencing. {#s3.3}
------------------------

Bacterial whole-genome sequencing was performed with Solexa single-read sequencing technology using a HiSeq 2000 system (Illumina) as previously described ([@B9]).

OGM of *A. baumannii* BM4587. {#s3.4}
-----------------------------

A whole-genome restriction map of BM4587 was produced through optical genome mapping (OGM) technology ([@B55]) using a MapCard kit and an enzyme kit-NcoI on an Argus system (OpGen Inc.). The map was aligned with the *in silico* restriction map predicted from contigs, allowing amplification of PCR products to cover the gaps in the sequence (see [Fig. S3](#figS3){ref-type="supplementary-material"} in the supplemental material). During gap coverage, we found a ca. 21-kb CDS between positions 774542 and 795637. By megablasting the 3,249-bp 5′ end and the 5,736-bp 3′ end, a biofilm-associated protein-encoding gene with repeated motifs, *bap* ([@B56]), was found, and its size was estimated to be 21,095 bp by OGM.

Annotation and comparative genome analysis. {#s3.5}
-------------------------------------------

CDSs were first predicted using AMIGene (Annotation of Microbial Genomes) software ([@B57]). Each CDS was then submitted to automatic functional annotation, and, as a final step, manual validation of automatic annotations was performed using the Mage web interface as previously described ([@B15]).

DNA manipulations and recombinant DNA techniques. {#s3.6}
-------------------------------------------------

*A. baumannii* genomic DNA was extracted using a Wizard genomic DNA purification kit (Promega). DNA amplification was performed in a GeneAmp 9700 PCR system (PerkinElmer Cetus) with Phusion High-Fidelity DNA polymerase (Thermo Scientific), and the PCR products were cloned in pCR-Blunt vector with *E. coli* NEB5α as the host strain. Nucleotide sequencing was carried out with a ceq 8000 DNA analysis system automatic sequencer (Beckman Instruments).

Construction of *A. baumannii* deleted for *adeB*, *adeG*, and *adeJ*. {#s3.7}
----------------------------------------------------------------------

The *adeB*, *adeG*, or *adeJ* gene was deleted by overlapping PCR and recombination according to the *sacB*-base strategy (see [Fig. S1](#figS1){ref-type="supplementary-material"} in the supplemental material) ([@B19]). Approximately 0.5-kb fragments upstream and downstream from the target genes were amplified from *A. baumannii* BM4587 genomic DNA using primer pairs adeB1/adeB2 and adeB3/adeB4, adeG1/adeG2 and adeG3/adeG4, or adeJ1/adeJ2 and adeJ3/adeJ4 (see [Table S5](#tabS5){ref-type="supplementary-material"} and [Fig. S1](#figS1){ref-type="supplementary-material"} in the supplemental material), linked by overlapping PCR with primer pairs adeB1/adeB4, adeG1/adeG4, or adeJ1/adeJ4, generating ca. 1-kb fragments that were cloned in pCR-Blunt with selection on kanamycin (50 µg/ml). After sequencing of the inserts, the plasmids were digested by BamHI and NsiI (Δ*adeB* and Δ*adeG*) or BamHI and PstI (Δ*adeJ*) and the resulting fragments were ligated to BamHI/NsiI-linearized pKNG101, generating pAT744, pAT745, and pAT746, respectively, which were introduced into *E. coli* DH5αλ*pir* ([@B58]) with selection on streptomycin (50 µg/ml). The recombinant plasmids were transferred to *A. baumannii* BM4587 by triparental mating. *E. coli* DH5αλ*pir* harboring pAT744, pAT745, or pAT746, *E. coli* HB101/pRK2013 (see [Table S2](#tabS2){ref-type="supplementary-material"}) ([@B59]), and recipient *A. baumannii* BM4587 were grown separately overnight at 37°C in LB supplemented with streptomycin for selection of the donors and kanamycin for the helper plasmid. Aliquots of 0.5 ml of the donor and helper strains were centrifuged, and the pellets were suspended to an optical density at 600 nm (OD~600~) of 4 in LB. Equal volumes were mixed, and 50-µl volumes were spotted on MH agar in duplicate and incubated at 37°C for 2 h. Fifty microliters of the recipient strain was plated on the spots, and conjugation was performed overnight at 37°C. Bacteria were collected and resuspended in 1 ml of LB, and 50-µl aliquots were spread on LB agar plates containing streptomycin (300 µg/ml) plus fosfomycin (60 µg/ml) for counterselection of the *E. coli* strains and incubated at 28°C for 3 days. Colonies were isolated, and single homologous recombination events were screened for by PCR with primer pairs adeB7/adeB4 and adeB1/adeB8 or primer pairs adeG7/adeG4 and adeG1/adeG8 or primer pairs adeJ4/adeJ7 and adeJ1/adeJ8. Transconjugants were then plated on LB agar containing 10% sucrose at 28°C for 24 to 48 h to induce expression of *sacB* and to select bacteria susceptible to sucrose. Deletion of the target genes was confirmed by PCR with primer pairs adeB7/adeB8, adeB7/adeB6, and adeB5/adeB8 or primer pairs adeG7/adeG8, adeG7/adeG6, and adeG5/adeG8 or primer pairs adeJ7/adeJ8, adeJ7/adeJ6, and adeJ5/adeJ8.

RNA isolation and RT-qPCR. {#s3.8}
--------------------------

*A. baumannii* total RNA was extracted from exponentially grown bacteria (OD~600~, 0.8 to 0.9) using TRIzol reagent (Invitrogen). RNA samples were treated with Turbo DNA-free kit (Applied Biosystems) to remove any genomic DNA carryover. Expression of genes *adeB*, *adeG*, and *adeJ* was quantified by RT-qPCR as previously described ([@B12]) using LightCycler RNA amplification kit SYBR green I (Roche Diagnostic) with the following cycle profile: 1 cycle at 95°C for 30 s, followed by 45 cycles at 95°C for 5 s, 56°C for 10 s, and 72°C for 20 s. The expression level of the *rpoB* gene of *A. baumannii* BM4587 was used as a reference ([@B12]). Each experiment was performed independently in duplicate at least twice.

Proteomic analyses. {#s3.9}
-------------------

Proteins from bacterial membranes of strains BM4587, BM4689\[↗*adeABC*\], and BM4666\[↗*adeIJK*\] were extracted from 4-h cultures as previously described ([@B29]). Briefly, after the bacterial pellets were washed twice with sterile phosphate-buffered saline (PBS), they were sonicated with a Branson Sonifier (Branson Ultrasonic) and incubated 30 min at 37°C in lysosyme (0.7% \[wt/vol\])--50 mM Tris-HCl (pH 7.4). Unbroken cells were eliminated by centrifugation at 10,000 ×g for 10 min at 4°C, and the supernatant was centrifuged at 100,000 × *g* for 45 min at 4°C. The (insoluble) pellet containing the cell envelope proteins was resuspended in 20 mM Tris-HCl (pH 7.4). Total protein content was determined by the Bradford assay. Protein separation on polyacrylamide gels, protein digestion by trypsin, and peptide extraction were performed as previously described ([@B29]). Peptide extracts were separated by the use of nano-liquid chromatography (nanoLC; Easy-nLC), and mass spectrometry analyses were performed on an LTQ-Orbitrap Elite system (Thermo Scientific) by injecting 1 µl of sample. For each strain, three independent extractions of membrane proteins were performed and two technical replicates of each extract were analyzed. For protein quantification and identification, we used Progenesis LC-MS software (Nonlinear Dynamics), retaining the same statistical parameters as previously described for peptides ([@B42]). The merged peak list was searched against the *A. baumannii* AYE database (<http://www.ncbi.nlm.nih.gov/protein>) using a local version of Mascot (version 2.2; Matrix Science). Protein fold change was taken into account when the value was above 2. At least 3 peptides were used for protein identification and quantification.

Biofilm assays. {#s3.10}
---------------

Biofilm formation by *A. baumannii* BM4587 and its derivatives was examined either on pegs using a Calgary device (Innovotech, Edmonton, Canada) for solid-support biofilms ([@B42]) or in 24-well plates for formation of biofilms together with pellicles ([@B42]). Biofilm biomass was quantified after 48 h of growth at 37°C by crystal violet staining as previously described ([@B42]). Assays were performed in triplicate at least, and data are expressed as means ± standard errors of the means (SE). Results were analyzed using Prism Graph Pad 5 software by a one-way analysis of variance (ANOVA) method to assess significant differences of biofilm growth between the strains.

Motility and transformation. {#s3.11}
----------------------------

Motility and transformation experiments were carried out as previously described ([@B36]). For both tests, plates were composed of 0.5% agarose, 5 g/liter tryptone, and 2.5 g/liter NaCl. The inoculum was stabbed into the semisolid medium to enable growth at the surface and at the interface between the agar and the bottom of the petri dish, and the plates were sealed with Parafilm to prevent drying. For the interface growth (twitching), the medium was allowed to air-dry for 5 min before the stabbing. Formation of a biofilm at the interface was visualized by crystal violet staining. For transformation, a suspension of a single colony in 20 µl of PBS was mixed with an equal volume of transforming DNA (400 to 800 ng/µl of DNA from kanamycin-resistant *A. baumannii* 179) ([@B36]) and stabbed into the motility plate (seven times, with 2 µl of the mixture used for each stabbing) and the Parafilm-sealed plates were incubated for 18 h at 37°C. The bacteria were then flushed from the motility medium with 1 ml of sterile PBS and plated on BHI agar containing 30 µg/ml of kanamycin. The number of CFU was determined for calculation of transformation rates. Effective transformation was determined on multiple colonies by PCR with 179-F and 179-R primers ([@B36]).

Plasmid transfer. {#s3.12}
-----------------

Spontaneous rifampin-resistant mutants from *A. baumannii* BM4587 and derivatives were isolated on LB agar containing 100 µg/ml of rifampin and used as recipients (see [Table S2](#tabS2){ref-type="supplementary-material"} in the supplemental material). For the liquid method, *A. baumannii* NIPH 527 with conjugative-system MPF~I~ integrated in the chromosome and harboring kanamycin-resistant plasmid pRAY ([@B38]) was used as a donor. Equal amounts of overnight cultures of the donor and of the recipient were mixed, incubated in LB for 5 h, and diluted. Transconjugants were selected by plating on LB agar containing rifampin (50 µg/ml) and kanamycin (50 µg/ml), purified, and tested by disk-agar diffusion. Plasmids were extracted from randomly selected transconjugants and digested by BamHI or HindIII, and the size of the resulting fragments was determined. For the standard filter method, *A. baumannii* BM2580 harboring self-transferable plasmid pIP1841 ([@B39]) was used as a donor. Equal amounts of donor and recipient overnight cultures in LB were harvested, washed with an equal volume of LB, and mixed on a mating filter (Millipore) placed on LB agar. After 5 h of mating at 37°C, cells were recovered and plated on LB agar with antibiotics selective for donors (kanamycin at 50 µg/ml), recipients (rifampin at 50 µg/ml), and transconjugants (kanamycin at 50 µg/ml and rifampin at 50 µg/ml). The frequency was calculated as the number of transconjugants per donor.

Nucleotide sequence accession number. {#s3.13}
-------------------------------------

The assembled sequence of *A. baumannii* BM4587 was submitted to the GenBank database and is accessible under accession number [JNOT00000000](JNOT00000000).

SUPPLEMENTAL MATERIAL {#sm1}
=====================
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Schematic representation of the two-step allelic exchange for deletion of RND pump genes in *A. baumannii* BM4587. (A) The upstream and downstream regions of the target gene were cloned in suicide vector pKNG101. (B) Recombinants after the first (a) or (b) crossing-over were selected by plating on LB agar containing streptomycin. (C) Deleted mutants were selected for loss of *sacB* by passage in medium containing sucrose. The second crossing-over could restore the parental genotype. The location of the PCR primers is indicated by arrowheads, forward in blue and reverse in red, and the numbers correspond to those in [Table S1](#tabS1){ref-type="supplementary-material"}. Download
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Motility on a semisolid medium. *A. baumannii* BM4587 and its derivatives were inoculated into a motility plate and incubated for 18 h at 37°C. Download
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Chromosome-circularizing strategy. The optical map derived from NcoI digestion of *A. baumannii* BM4587 chromosome is presented as a single contig (middle) and the NcoI *in silico* digestion of 24 contigs as a corresponding match to the optical map (top and bottom). Blue regions, perfect alignment; white regions, no alignment; vertical black bars, NcoI restriction sites; WGS, whole-genome sequencing. Download
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###### 

Table S3, DOCX file, 0.1 MB

###### 

Antibiotic susceptibility of *A. baumannii* harboring pCM88.

###### 

Table S4, DOCX file, 0.1 MB

###### 

Oligonucleotides used in this study.

###### 

Table S5, DOCX file, 0.1 MB

**Citation** Yoon E, Nait Chabane Y, Goussard S, Snesrud E, Courvalin P, Dé E, Grillot-Courvalin C. 2015. Contribution of resistance-nodulation-cell division efflux systems to antibiotic resistance and biofilm formation in *Acinetobacter baumannii.* mBio 6(2):e00309-15. doi:10.1128/mBio.00309-15.

We thank C. Bouchier for whole-genome sequencing, G. Wilharm for the gift of *A. baumannii* 179 DNA, V. Barbe for optical genome mapping and helpful discussions, and the platform Genotyping of Pathogens and Public Health, Institut Pasteur, for coding multilocus sequence type (MLST) alleles and profiles available at <http://www.pasteur.fr/mlst>.

E.-J.Y. was supported by an unrestricted grant from Reckitt-Benckiser.

[^1]: This article is a direct contribution from a Fellow of the American Academy of Microbiology.
